CPTx
PrivateLast Round
Grant
Aug 14, 2025
Total Funding Raised
$30.16M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CPTx is a biotechnology company that develops in vivo genetic medicines and antiviral solutions using an immune-silent single-stranded DNA (ssDNA) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CPTx Comparables
Compare CPTx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoCell Therapeutics | 87% | |
| Stylus Medicine | 84% | |
| AbbVie | 84% |
CPTx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 14, 2025 | ||||
| Early Funding | Sep 12, 2024 |
Key People
Founding team and executive leadership
CPTx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eureka Network | Grant |
| BlueYard Capital | Early Funding |
| Bayern Kapital | Early Funding |
| European Union | Grant |
| SPRIND | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors increased 160% MoM.
- Sep 3, 2025
David Maier appointed to lead gxstrands business unit.
Recent news
Latest coverage and updates
- hiresSep 8, 2026
CPTx hired Matt Kane as Chief Financial Officer on Sep 8th '26.
CPTx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CPTx's valuation, stock price, and market status.
Is CPTx a public or private company?
CPTx is a private company.
What is the current stock price of CPTx?
CPTx is a private company with no public stock price. No recent secondary market data is available.
How much is CPTx worth (valuation)?
Valuation information for CPTx is not publicly available.
Can I buy CPTx stock?
CPTx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CPTx's last funding round?
CPTx's most recent funding round was Grant on August 14, 2025.
Who are the main investors in CPTx?
Key investors in CPTx include BlueYard Capital, SPRIND.
Will CPTx IPO soon?
No public IPO plans have been announced for CPTx.
How can I track CPTx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CPTx's secondary market activity and sign up for updates.